Expanded Indication for LIPOSORBER® LA-15 System
February 3, 2025
New York, January 29, 2025 We are pleased to announce an important update regarding Kaneka’s LIPOSORBER® LA-15 System Indications for clinically diagnosed Familial Hypercholesterolemic patients. As part of our ongoing commitment to advance patient care and support healthcare providers in properly managing these patients, we have received approval for improved indications that enhance the utility
